Stylissamide G linear

General Information


DRACP ID  DRACP03690

Peptide Name   Stylissamide G linear

Sequence  LIPFPFP

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Boc

C-terminal Modification  OMe

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H63N7O8

Absent amino acids  ACDEGHKMNQRSTVWY

Common amino acids  P

Mass  93723

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  1580

Hydrophobicity  130

Aliphatic Index  111.43

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27983681

Title  First Total Synthesis and Biological Screening of a Proline-Rich Cyclopeptide from a Caribbean Marine Sponge

Doi Not available

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11239

DRACP is developed by Dr.Zheng's team.